Dergiler / Medicine Science / 2012 / Cilt: 1 Sayı: 1

Oxidative Stress Status, Metabolic Profile and Cardiovascular Risk Factors in Patients with Polycystic Ovary Syndrome

Sayfa
27–34
Yayın Tarihi
2012-03-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Our results revealed that PCOS is associated with imbalanced oxidative/antioxidative status, impaired metabolic profile and increased cardiovascular risk factors.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:We aimed to investigate the relationships between Polycystic Ovary Syndrome (PCOS) and oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome Methods: We measured Body Mass Index (BMI), glucose, cholesterol, triglyceride, HDL, LDL, high sensitive CRP (hsCRP), insulin, AST and ALT, Malondialdehyde (MDA), erythrocyte reduced glutathione (GSH), Nitric Oxide (NO) levels in PCOS patients and in normal individuals.
📊
Temel Bulgular & Veri:Results: Study population were consist of 32 women with PCOS (Study group) and 32 healthy volunteers (Control group).
💡
Sonuç & Katkı:Conclusion: Our results revealed that PCOS is associated with imbalanced oxidative/antioxidative status, impaired metabolic profile and increased cardiovascular risk factors.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:PCOS · oxidants · antioxidants

Özet

We aimed to investigate the relationships between Polycystic Ovary Syndrome (PCOS) and oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome Methods: We measured Body Mass Index (BMI), glucose, cholesterol, triglyceride, HDL, LDL, high sensitive CRP (hsCRP), insulin, AST and ALT, Malondialdehyde (MDA), erythrocyte reduced glutathione (GSH), Nitric Oxide (NO) levels in PCOS patients and in normal individuals. We used spectrophotometrical method to determine glucose, cholesterol, triglyceride, HDL, LDL, AST and ALT levels. Nepholometrical method was used to measure hsCRP. Immunoassay method was used for insulin. Oxidant status was evaluated by using erythrocyte MDA and NO levels, while antioxidant status was evaluated by GSH levels. Results: Study population were consist of 32 women with PCOS (Study group) and 32 healthy volunteers (Control group). In study group, we found statistically higher levels of MDA, NO (p<0.001) and lower levels of GSH (p<0.001) compared to those of controls. hsCRP, insulin (p<0.001) and triglyceride (p<0.05) levels were statistically higher in study group. We also observed a statistically higher BMI in women with PCOS (p<0.05). Conclusion: Our results revealed that PCOS is associated with imbalanced oxidative/antioxidative status, impaired metabolic profile and increased cardiovascular risk factors.

Abstract

We aimed to investigate the relationships between Polycystic Ovary Syndrome (PCOS) and oxidative stress status, metabolic profile and cardiovascular risk factors in patients with polycystic ovary syndrome Methods: We measured Body Mass Index (BMI), glucose, cholesterol, triglyceride, HDL, LDL, high sensitive CRP (hsCRP), insulin, AST and ALT, Malondialdehyde (MDA), erythrocyte reduced glutathione (GSH), Nitric Oxide (NO) levels in PCOS patients and in normal individuals. We used spectrophotometrical method to determine glucose, cholesterol, triglyceride, HDL, LDL, AST and ALT levels. Nepholometrical method was used to measure hsCRP. Immunoassay method was used for insulin. Oxidant status was evaluated by using erythrocyte MDA and NO levels, while antioxidant status was evaluated by GSH levels. Results: Study population were consist of 32 women with PCOS (Study group) and 32 healthy volunteers (Control group). In study group, we found statistically higher levels of MDA, NO (p<0.001) and lower levels of GSH (p<0.001) compared to those of controls. hsCRP, insulin (p<0.001) and triglyceride (p<0.05) levels were statistically higher in study group. We also observed a statistically higher BMI in women with PCOS (p<0.05). Conclusion: Our results revealed that PCOS is associated with imbalanced oxidative/antioxidative status, impaired metabolic profile and increased cardiovascular risk factors.

🔖

Bu Makaleye Atıf Yap

K, E., F, Y., M, O., M, C., T, T. U., Y, K. (2012). Oxidative Stress Status, Metabolic Profile and Cardiovascular Risk Factors in Patients with Polycystic Ovary Syndrome. Medicine Science, Cilt: 1 Sayı: 1, 27–34. https://ajindex.com/articles/1003373

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Lee H, Oh JY, Sung YA, Chung H, Cho WY. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome Endocrine. 2009;36(2):326-32. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
  2. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57(2):356-9.
  3. Kuscu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2009;88(5):612-7.
  4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165-74.
  5. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34:407-13.
  6. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336-40.
  7. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28. Verit FF, Erel O. Oxidative stress in non-obese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest. 2008;65:233-9.
  8. Bickerton AS, Clark N, Meeking D, Shaw KM, Crook M, Lumb P, Turner C, Cummings MH. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol. 2005;58(2):151-4.
  9. Ruschitzka FT, Noll G, Luscher TF. The endothelium in coronary artery disease. Cardiology. 1997;88:3-19.
  10. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119(4):356.e 1-6.
  11. Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest. 2006;36:691-7.
  12. Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab. 2005;90:5711-6.
  13. Karadeniz M, Erdogan M, Tamsel S,